(A021) MicroVue C5a EIA

A sandwich (quantitative) elisa kit, supplied by QuidelOrtho, cited in 50 publications. Reactivity includes Human.

Go to:

Supplier info

50 citations

General Information

Supplier

QuidelOrtho

Kit Type

ELISA

Assay Type

Sandwich (Quantitative)

Supplier provided information

Validations

None provided

Reactivity

None provided

Sample Type

None provided

Comments

for this reagent

Add your comment here...

Enabling you to share comments privately within your lab, helping to avoid duplicated effort.

Get free early access and help us shape this new feature. Join the private beta

0 images

50 citations

found in the literature

Reactivity

Homo sapiens (Human)

Sample type

None Available

Published images

We have not yet identified suitable images that show this product being used, more are being added all the time.

Loading published images for this product

Th2 predominance and decreased NK cells in patients with hereditary angioedema.

View PDF

In Frontiers in Immunology on 29 May 2025 by Sundler Björkman, L., Elmér, E., et al.

Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity.

View PDF

In Critical Care on 16 February 2023 by de Nooijer, A. H., Kotsaki, A., et al.

Reactivity:

Homo sapiens (Human)

Serum and plasma levels of Ba, but not those of soluble C5b-9, might be affected by renal function in chronic kidney disease patients.

View Preprint View PDF

In BMC Nephrology on 2 February 2023 by Yamane, R., Yasuda, Y., et al.

Reactivity:

Homo sapiens (Human)

Circulating immune-complexes and complement activation through the classical pathway in myeloperoxidase-ANCA-associated glomerulonephritis.

View PDF

In Renal Failure on 1 December 2022 by Kojima, T., Inoue, D., et al.

Reactivity:

Homo sapiens (Human)

High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsets.

View PDF

In Clinical and Experimental Rheumatology on 1 November 2022 by Ruffatti, A., Tonello, M., et al.

Reactivity:

Homo sapiens (Human)

CipA mediates complement resistance of Acinetobacter baumannii by formation of a factor I-dependent quadripartite assemblage.

View PDF

In Frontiers in Immunology on 13 August 2022 by Ries, J. I., Heß, M., et al.

Reactivity:

Homo sapiens (Human)

Plasma C4 level was associated with mortality, cardiovascular and cerebrovascular complications in hemodialysis patients.

View Preprint View PDF

In BMC Nephrology on 29 June 2022 by Xing, Z., Wang, Y., et al.

Reactivity:

Homo sapiens (Human)

Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis.

View PDF

In Kidney International Reports on 1 May 2022 by Genest, D. S., Bonnefoy, A., et al.

Reactivity:

Homo sapiens (Human)

Complement Activation in Patients With Heat-Related Illnesses: Soluble CD59 Is a Novel Biomarker Indicating Severity of Heat-Related Illnesses.

View PDF

In Critical Care Explorations on 1 April 2022 by Nakamura, Y., Sueyoshi, K., et al.

Reactivity:

Homo sapiens (Human)

Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.

View PDF

In Medical Microbiology and Immunology on 1 February 2022 by Leatherdale, A., Stukas, S., et al.

Reactivity:

Homo sapiens (Human)

(A021) MicroVue C5a EIA

General Information

Supplier provided information

Validations

Reactivity

Sample Type

Comments

for this reagent

0 images

50 citations

found in the literature

Reactivity

Sample type

Published images

Calculators

Report a Problem

(A021) MicroVue C5a EIA

General Information

Supplier provided information

Validations

Reactivity

Sample Type

Comments for this reagent

0 images 50 citations found in the literature

Reactivity

Sample type

Published images

Calculators

Report a Problem

40 more citations

Join thousands of people who already enjoy the CiteAb newsletter

Comments

for this reagent

0 images

50 citations

found in the literature